These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3095301)

  • 21. In-vitro activity of BRL-36650, a novel beta-lactamase-stable penicillin, against multiply resistant gram-negative organisms.
    Verbist L
    J Antimicrob Chemother; 1986 Sep; 18(3):351-8. PubMed ID: 3095299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of temocillin on human bowel flora.
    Mittermayer HW
    Drugs; 1985; 29 Suppl 5():43-8. PubMed ID: 3849424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic results and tissue concentrations of temocillin in surgical patients.
    Wittke RR; Adam D; Klein HE
    Drugs; 1985; 29 Suppl 5():221-6. PubMed ID: 4029028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temocillin penetration of peripheral lymph.
    Bergan T; Olszewski WL; Engeset A
    Drugs; 1985; 29 Suppl 5():114-7. PubMed ID: 4029013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of temocillin, moxalactam and cefotaxime against gram negative bacteria sensitive or resistant to ureidopenicillins and/or cefacedone.
    Bartmann K; Tarbuc R
    Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Dec; 256(2):202-10. PubMed ID: 6324518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temocillin. In vitro activity compared with other antibiotics.
    Martinez-Beltran J; Loza E; Gomez-Alferez A; Romero-Vivas J; Bouza E
    Drugs; 1985; 29 Suppl 5():91-7. PubMed ID: 3875477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and tissue penetration of temocillin.
    Lockley MR; Brown RM; Wise R
    Drugs; 1985; 29 Suppl 5():106-8. PubMed ID: 4029011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of temocillin on colonisation resistance and consequences for therapy.
    De Vries-Hospers HG; Hofstra W; Welling GW; Van der Waaij D
    Drugs; 1985; 29 Suppl 5():227-33. PubMed ID: 3849422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temocillin dosage adjustment in a preterm infant with severe renal disease: a case report.
    Dumangin G; Brenkman M; Pape E; Kolodziej A; Gambier N; Vrillon I; Charmillon A; Scala-Bertola J
    J Antimicrob Chemother; 2020 Dec; 75(12):3652-3655. PubMed ID: 32814946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biliary concentrations of temocillin.
    Poston GJ; Greengrass A; Moryson CJ
    Drugs; 1985; 29 Suppl 5():140-5. PubMed ID: 4029018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temocillin. Summary of safety studies.
    Cockburn A; Mellows G; Jackson D; White DJ
    Drugs; 1985; 29 Suppl 5():103-5. PubMed ID: 4029010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A disc diffusion assay for detection of class A, B and OXA-48 carbapenemases in Enterobacteriaceae using phenyl boronic acid, dipicolinic acid and temocillin.
    van Dijk K; Voets GM; Scharringa J; Voskuil S; Fluit AC; Rottier WC; Leverstein-Van Hall MA; Cohen Stuart JW
    Clin Microbiol Infect; 2014 Apr; 20(4):345-9. PubMed ID: 23927659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temocillin pharmacokinetics in normal and impaired renal function.
    Höffler D; Koeppe P
    Drugs; 1985; 29 Suppl 5():135-9. PubMed ID: 4029017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacteriostatic and bactericidal activity of penicillins at constant and variable concentrations.
    Bauernfeind A
    Drugs; 1985; 29 Suppl 5():9-14. PubMed ID: 3875476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibacterial activity of temocillin.
    Malottke R; Potel J
    Drugs; 1985; 29 Suppl 5():67-73. PubMed ID: 3849426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of intrinsic resistance and acquired susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients to temocillin, a revived antibiotic.
    Chalhoub H; Pletzer D; Weingart H; Braun Y; Tunney MM; Elborn JS; Rodriguez-Villalobos H; Plésiat P; Kahl BC; Denis O; Winterhalter M; Tulkens PM; Van Bambeke F
    Sci Rep; 2017 Jan; 7():40208. PubMed ID: 28091521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. -carboxy-3-thienylmethylpenicillin (BRL 2288), a new semisynthetic penicillin: absorption and excretion in man.
    Sutherland R; Wise PJ
    Antimicrob Agents Chemother (Bethesda); 1970; 10():402-6. PubMed ID: 5521361
    [No Abstract]   [Full Text] [Related]  

  • 38. The intraperitoneal penetration of temocillin.
    Wise R; Donovan IA; Drumm J; Dyas A; Cross C
    J Antimicrob Chemother; 1983 Jul; 12(1):93-6. PubMed ID: 6619048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15.
    Soubirou JF; Rossi B; Couffignal C; Ruppé E; Chau F; Massias L; Lepeule R; Mentre F; Fantin B
    J Antimicrob Chemother; 2015 May; 70(5):1466-72. PubMed ID: 25564564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration.
    Laterre PF; Wittebole X; Van de Velde S; Muller AE; Mouton JW; Carryn S; Tulkens PM; Dugernier T
    J Antimicrob Chemother; 2015 Mar; 70(3):891-8. PubMed ID: 25433006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.